A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk

Pediatric Blood and Cancer

Volumn 61, Issue 5, 2014, Pages 771-777

  Li, Cuiping ^a   Liu, Yun ^a   Wei, Shujiao ^b   Zhou, Yang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Guangxi Centers for Disease Prevention and Control   (China)

Author keywords

Acute myeloblastic leukemia; Meta analysis; NQO1; Polymorphism

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ACUTE GRANULOCYTIC LEUKEMIA; ADULT DISEASE; ARTICLE; ASIAN; CANCER RISK; CHILDHOOD CANCER; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW;

ACUTE MYELOBLASTIC LEUKEMIA; META-ANALYSIS; NQO1; POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84895765589     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24924     Document Type: Article

References (43)

1. Meenaghan T, Dowling M, Kelly M. Acute leukaemia: Making sense of a complex blood cancer. Br J Nurs 2012; 21:76, 78-83.
2. Advani AS, Hunger SP, Burnett AK. Acute leukemia in adolescents and young adults. Semin Oncol 2009; 36:213-226.
3. Ilhan G, Karakus S, Andic N. Risk factors and primary prevention of acute leukemia. Asian Pac J Cancer Prev 2006; 7:515-517.
4. Schlager JJ, Powis G. Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 1990; 45:403-409.
5. Joseph P, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501 A1 and P450 reductase. Proc Natl Acad Sci USA 1994; 91:8413-8417.
6. Nebert DW, Roe AL, Vandale SE, et al. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genet Med 2002; 4:62-70.
7. Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: Role as a superoxide scavenger. Mol Pharmacol 2004; 65:1238-1247.
8. Traver RD, Horikoshi T, Danenberg KD, et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 1992; 52:797-802.
9. Traver RD, Siegel D, Beall HD, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 1997; 75:69-75.
10. Moran JL, Siegel D, Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 1999; 96:8150-8155.
11. Siegel D, McGuinness SM, Winski SL, et al. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 1999; 9:113-121.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
13. Cochran WG. The comparison of percentages in matched samples. Biometrika 1950; 37:256-266.
14. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
15. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-1101.
16. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
17. Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers 2013; 17:195-201.
18. de Aguiar Goncalves BA, Vasconcelos GM, Thuler LC, et al. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control 2012; 23:1811-1819.
19. Jia MF, Xi YM, Shi XE, et al. [Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:1336-1340.
20. Zaker F. Safaei A, Hashemi M, et al. The frequency and association of C609T and C465T polymorphisms of NAD(P)H:quinone oxidoreductase gene with adult acute myeloid leukemia. Science 2011; 674-677.
21. Yamaguti GG, Lourenco GJ, Costa FF, et al. High risk of "de novo" acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects. Eur J Haematol 2009; 83:270-272.
22. Bolufer P, Collado M, Barragan E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007; 92:308-314.
23. Voso MT, Fabiani E, D'Alo F, et al. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol 2007; 18:1523-1528.
24. Malik E, Cohen SB, Sahar D, et al. The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients. Haematologica 2006; 91:956-959.
25. Eguchi-Ishimae M, Eguchi M, Ishii E, et al. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 2005; 90:1511-1515.
26. Yang L, Zhang Y, Zhang MR, et al. [Relationship between GSTT1, GSTM1 and NQO1 gene polymorphism and acute myeloid leukemia and recurrent chromosome translocations]. Zhonghua Yi Xue Za Zhi 2005; 85:2312-2316.
27. Sirma S, Agaoglu L, Yildiz I, et al. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 2004; 43:568-570.
28. Seedhouse C, Bainton R, Lewis M, et al. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002; 100:3761-3766.
29. Naoe T, Takeyama K, Yokozawa T, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000; 6:4091-4095.
30. Jianwang Xu, Xe S, Mingfeng Jia, et al. Relationship between NQO1 gene polymorphisms and susceptibility of acute myeloid leukemia in Gansu population. J Clin Hematol 2010; 23:718-720.
31. Long DJ II, Gaikwad A, Multani A, et al. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res 2002; 62:3030-3036.
32. Greaves M. Infection immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6:193-203.
33. Vijayakrishnan J, Houlston RS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Haematologica 2010; 95:1405-1414.
34. Infante-Rivard C, Vermunt JK, Weinberg CR. Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. Am J Epidemiol 2007; 165:1248-1254.
35. Swinney RM, Beuten J, Collier AB III, et al. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol Biomarkers Prev 2011; 20:1537-1542.
36. Chao C, Zhang ZF, Berthiller J, et al. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:979-987.
37. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002; 100:1957-1964.
38. Kracht T, Schrappe M, Strehl S, et al. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica 2004; 89:1492-1497.
39. Perera FP. Environment and cancer: Who are susceptible? Science 1997; 278:1068-1073.
40. Larfors G, Hallbook H, Simonsson B. Parental age, family size, and offspring's risk of childhood and adult acute leukemia. Cancer Epidemiol Biomarkers Prev 2012; 21:1185-1190.
41. Juhl-Christensen C, Ommen HB, Aggerholm A, et al. Genetic and epigenetic similarities and differences between childhood and adult AML. Pediatr Blood Cancer 2012; 58:525-531.
42. Guha N, Chang JS, Chokkalingam AP, et al. NQO1 polymorphisms and de novo childhood leukemia: A HuGE review and meta-analysis. Am J Epidemiol 2008; 168:1221-1232.
43. Ross D. Metabolic basis of benzene toxicity. Eur J Haematol Suppl 1996; 60:111-118.